Water Island Capital LLC acquired a new position in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 17,000 shares of the biotechnology company’s stock, valued at approximately $139,000. Other hedge funds have also recently made changes to their positions in the company. Amalgamated Bank […]
KGI Securities started coverage on shares of Pacific Biosciences of California (NASDAQ:PACB – Get Rating) in a report released on Wednesday, The Fly reports. The brokerage issued an outperform rating on the biotechnology company’s stock. A number of other equities analysts have also commented on PACB. Piper Sandler raised their target price on shares of […]
Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the ten analysts that are covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month […]
KGI Securities initiated coverage on shares of Pacific Biosciences of California (NASDAQ:PACB – Get Rating) in a research report sent to investors on Wednesday morning, The Fly reports. The brokerage issued an outperform rating on the biotechnology company’s stock. A number of other analysts also recently weighed in on the stock. Barclays began coverage on […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Rating)’s stock price traded down 5.6% during mid-day trading on Tuesday . The stock traded as low as $12.22 and last traded at $12.33. 2,694,787 shares traded hands during mid-day trading, a decline of 32% from the average session volume of 3,985,243 shares. The stock had previously […]